{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:43:51Z","timestamp":1790196231871,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-025-11961-y","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T16:28:39Z","timestamp":1755707319000},"page":"1158-1169","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prognostic value of late gadolinium enhancement on cardiac magnetic resonance imaging for non-sustained ventricular tachycardia and sudden cardiac death in hypertrophic cardiomyopathy: a meta-analysis"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5612-8626","authenticated-orcid":false,"given":"Ahmed Kamal","family":"Siddiqi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Talha","family":"Maniya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozlem","family":"Bilen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Abdou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo N.","family":"De Cecco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Naeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"key":"11961_CR1","doi-asserted-by":"publisher","unstructured":"Authors\/Task Force Members, Elliott PM, Anastasakis A et al (2014) 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 35:2733\u20132779. https:\/\/doi.org\/10.1093\/eurheartj\/ehu284","DOI":"10.1093\/eurheartj\/ehu284"},{"key":"11961_CR2","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0002-9149(01)01640-X","volume":"88","author":"AM Varnava","year":"2001","unstructured":"Varnava AM, Elliott PM, Mahon N et al (2001) Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy. Am J Cardiol 88:275\u2013279. https:\/\/doi.org\/10.1016\/S0002-9149(01)01640-X","journal-title":"Am J Cardiol"},{"key":"11961_CR3","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/europace\/eup431","volume":"12","author":"I Christiaans","year":"2010","unstructured":"Christiaans I, Van Engelen K, Van Langen IM et al (2010) Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers. Europace 12:313\u2013321. https:\/\/doi.org\/10.1093\/europace\/eup431","journal-title":"Europace"},{"key":"11961_CR4","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.5603\/KP.2014.0212","volume":"72","author":"PM Elliott","year":"2014","unstructured":"Elliott PM, Anastasakis A, Borger MA et al (2014) 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy. Kardiol Pol 72:1054\u20131126. https:\/\/doi.org\/10.5603\/KP.2014.0212","journal-title":"Kardiol Pol"},{"key":"11961_CR5","doi-asserted-by":"publisher","first-page":"e159","DOI":"10.1016\/j.jacc.2020.08.045","volume":"76","author":"SR Ommen","year":"2020","unstructured":"Ommen SR, Mital S, Burke MA et al (2020) 2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 76:e159\u2013e240. https:\/\/doi.org\/10.1016\/j.jacc.2020.08.045","journal-title":"J Am Coll Cardiol"},{"key":"11961_CR6","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.amjcard.2015.05.047","volume":"116","author":"BJ Maron","year":"2015","unstructured":"Maron BJ, Casey SA, Chan RH et al (2015) Independent assessment of the European Society of Cardiology sudden death risk model for hypertrophic cardiomyopathy. Am J Cardiol 116:757\u2013764. https:\/\/doi.org\/10.1016\/j.amjcard.2015.05.047","journal-title":"Am J Cardiol"},{"key":"11961_CR7","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/j.jacc.2011.12.063","volume":"60","author":"DG Katritsis","year":"2012","unstructured":"Katritsis DG, Zareba W, Camm AJ (2012) Nonsustained ventricular tachycardia. J Am Coll Cardiol 60:1993\u20132004. https:\/\/doi.org\/10.1016\/j.jacc.2011.12.063","journal-title":"J Am Coll Cardiol"},{"key":"11961_CR8","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1002\/clc.23425","volume":"43","author":"L Liu","year":"2020","unstructured":"Liu L, Liu S, Shen L et al (2020) Correlations between cardiac troponin I and nonsustained ventricular tachycardia in hypertrophic obstructive cardiomyopathy. Clin Cardiol 43:1150\u20131159. https:\/\/doi.org\/10.1002\/clc.23425","journal-title":"Clin Cardiol"},{"key":"11961_CR9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.116.004604","volume":"10","author":"W Wang","year":"2017","unstructured":"Wang W, Lian Z, Rowin EJ et al (2017) Prognostic implications of nonsustained ventricular tachycardia in high-risk patients with hypertrophic cardiomyopathy. Circ Arrhythm Electrophysiol 10:e004604. https:\/\/doi.org\/10.1161\/CIRCEP.116.004604","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"11961_CR10","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S0735-1097(03)00827-1","volume":"42","author":"L Monserrat","year":"2003","unstructured":"Monserrat L, Elliott PM, Gimeno JR et al (2003) Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy. J Am Coll Cardiol 42:873\u2013879. https:\/\/doi.org\/10.1016\/S0735-1097(03)00827-1","journal-title":"J Am Coll Cardiol"},{"key":"11961_CR11","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/0002-9149(81)90604-4","volume":"48","author":"BJ Maron","year":"1981","unstructured":"Maron BJ, Savage DD, Wolfson JK, Epstein SE (1981) Prognostic significance of 24\u2009h ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study. Am J Cardiol 48:252\u2013257. https:\/\/doi.org\/10.1016\/0002-9149(81)90604-4","journal-title":"Am J Cardiol"},{"key":"11961_CR12","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1007\/s00380-019-01549-0","volume":"35","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Yu M, Yuan J et al (2020) Cardiac troponin I is associated with non-sustained ventricular tachycardia in patients with hypertrophic obstructive cardiomyopathy. Heart Vessels 35:876\u2013885. https:\/\/doi.org\/10.1007\/s00380-019-01549-0","journal-title":"Heart Vessels"},{"key":"11961_CR13","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1001\/jama.287.10.1308","volume":"287","author":"BJ Maron","year":"2002","unstructured":"Maron BJ (2002) Hypertrophic cardiomyopathy: a systematic review. JAMA 287:1308\u20131320. https:\/\/doi.org\/10.1001\/jama.287.10.1308","journal-title":"JAMA"},{"key":"11961_CR14","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1253\/circj.CJ-13-1423","volume":"78","author":"D Magr\u00ec","year":"2014","unstructured":"Magr\u00ec D, De Cecco CN, Piccirillo G et al (2014) Myocardial repolarization dispersion and late gadolinium enhancement in patients with hypertrophic cardiomyopathy. Circ J 78:1216\u20131223. https:\/\/doi.org\/10.1253\/circj.CJ-13-1423","journal-title":"Circ J"},{"key":"11961_CR15","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1007\/s10554-016-0954-5","volume":"32","author":"E Pozo","year":"2016","unstructured":"Pozo E, Viliani D, Aguirre N et al (2016) Early gadolinium enhancement in hypertrophic cardiomyopathy: a potential premature marker of myocardial damage. Int J Cardiovasc Imaging 32:1635\u20131643. https:\/\/doi.org\/10.1007\/s10554-016-0954-5","journal-title":"Int J Cardiovasc Imaging"},{"key":"11961_CR16","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jcmg.2011.11.021","volume":"5","author":"JJ Green","year":"2012","unstructured":"Green JJ, Berger JS, Kramer CM, Salerno M (2012) Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy. JACC Cardiovasc Imaging 5:370\u2013377. https:\/\/doi.org\/10.1016\/j.jcmg.2011.11.021","journal-title":"JACC Cardiovasc Imaging"},{"key":"11961_CR17","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.jacc.2007.11.071","volume":"51","author":"AS Adabag","year":"2008","unstructured":"Adabag AS, Maron BJ, Appelbaum E et al (2008) Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 51:1369\u20131374. https:\/\/doi.org\/10.1016\/j.jacc.2007.11.071","journal-title":"J Am Coll Cardiol"},{"key":"11961_CR18","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/clc.23445","volume":"43","author":"H Chung","year":"2020","unstructured":"Chung H, Park C, Kim Y et al (2020) Burden of premature ventricular contractions beyond nonsustained ventricular tachycardia is related to the myocardial extracellular space expansion in patients with hypertrophic-cardiomyopathy. Clin Cardiol 43:1317\u20131325. https:\/\/doi.org\/10.1002\/clc.23445","journal-title":"Clin Cardiol"},{"key":"11961_CR19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1161\/CIRCHEARTFAILURE.109.854026","volume":"3","author":"R Rubinshtein","year":"2010","unstructured":"Rubinshtein R, Glockner JF, Ommen SR et al (2010) Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Circ Heart Fail 3:51\u201358. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.109.854026","journal-title":"Circ Heart Fail"},{"key":"11961_CR20","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1016\/S0735-1097(02)02602-5","volume":"40","author":"L Choudhury","year":"2002","unstructured":"Choudhury L, Mahrholdt H, Wagner A et al (2002) Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 40:2156\u20132164. https:\/\/doi.org\/10.1016\/S0735-1097(02)02602-5","journal-title":"J Am Coll Cardiol"},{"key":"11961_CR21","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1136\/heartjnl-2013-305471","volume":"100","author":"TF Ismail","year":"2014","unstructured":"Ismail TF, Jabbour A, Gulati A et al (2014) Role of late gadolinium enhancement cardiovascular magnetic resonance in the risk stratification of hypertrophic cardiomyopathy. Heart 100:1851\u20131858. https:\/\/doi.org\/10.1136\/heartjnl-2013-305471","journal-title":"Heart"},{"key":"11961_CR22","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.amjcard.2007.09.101","volume":"101","author":"BJ Maron","year":"2008","unstructured":"Maron BJ, Maron MS, Lesser JR et al (2008) Sudden cardiac arrest in hypertrophic cardiomyopathy in the absence of conventional criteria for high risk status. Am J Cardiol 101:544\u2013547. https:\/\/doi.org\/10.1016\/j.amjcard.2007.09.101","journal-title":"Am J Cardiol"},{"key":"11961_CR23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jjcc.2015.07.020","volume":"68","author":"M Klopotowski","year":"2016","unstructured":"Klopotowski M, Kukula K, Malek LA et al (2016) The value of cardiac magnetic resonance and distribution of late gadolinium enhancement for risk stratification of sudden cardiac death in patients with hypertrophic cardiomyopathy. J Cardiol 68:49\u201356. https:\/\/doi.org\/10.1016\/j.jjcc.2015.07.020","journal-title":"J Cardiol"},{"key":"11961_CR24","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.jcmg.2023.07.005","volume":"17","author":"A Kiaos","year":"2024","unstructured":"Kiaos A, Daskalopoulos GN, Kamperidis V et al (2024) Quantitative late gadolinium enhancement cardiac magnetic resonance and sudden death in hypertrophic cardiomyopathy: a meta-analysis. JACC Cardiovasc Imaging 17:489\u2013497. https:\/\/doi.org\/10.1016\/j.jcmg.2023.07.005","journal-title":"JACC Cardiovasc Imaging"},{"key":"11961_CR25","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.amjcard.2013.12.034","volume":"113","author":"BM Smith","year":"2014","unstructured":"Smith BM, Dorfman AL, Yu S et al (2014) Clinical significance of late gadolinium enhancement in patients <20 years of age with hypertrophic cardiomyopathy. Am J Cardiol 113:1234\u20131239. https:\/\/doi.org\/10.1016\/j.amjcard.2013.12.034","journal-title":"Am J Cardiol"},{"key":"11961_CR26","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.mri.2003.08.009","volume":"22","author":"K Teraoka","year":"2004","unstructured":"Teraoka K, Hirano M, Ookubo H et al (2004) Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy. Magn Reson Imaging 22:155\u2013161. https:\/\/doi.org\/10.1016\/j.mri.2003.08.009","journal-title":"Magn Reson Imaging"},{"key":"11961_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-021-01626-4","volume":"10","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev 10: 89. https:\/\/doi.org\/10.1186\/s13643-021-01626-4","journal-title":"Syst Rev"},{"key":"11961_CR28","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.7326\/M22-0276","volume":"175","author":"J Lee","year":"2022","unstructured":"Lee J, Mulder F, Leeflang M et al (2022) QUAPAS: an adaptation of the QUADAS-2 tool to assess prognostic accuracy studies. Ann Intern Med 175:1010\u20131018. https:\/\/doi.org\/10.7326\/M22-0276","journal-title":"Ann Intern Med"},{"key":"11961_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S1885-5857(07)60101-7","volume":"60","author":"C Dumont","year":"2007","unstructured":"Dumont C, Monserrat L, Soler R et al (2007) Clinical significance of late gadolinium enhancement on cardiac magnetic resonance in patients with hypertrophic cardiomyopathy. Rev Esp Cardiol 60:15\u201323. https:\/\/doi.org\/10.1016\/S1885-5857(07)60101-7","journal-title":"Rev Esp Cardiol"},{"key":"11961_CR30","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10554-007-9209-9","volume":"24","author":"PP Dimitrow","year":"2007","unstructured":"Dimitrow PP, Klimeczek P, Vliegenthart R et al (2007) Late hyperenhancement in gadolinium-enhanced magnetic resonance imaging: comparison of hypertrophic cardiomyopathy patients with and without nonsustained ventricular tachycardia. Int J Cardiovasc Imaging 24:77\u201383. https:\/\/doi.org\/10.1007\/s10554-007-9209-9","journal-title":"Int J Cardiovasc Imaging"},{"key":"11961_CR31","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.cardfail.2008.02.006","volume":"14","author":"E Pay\u00e1","year":"2008","unstructured":"Pay\u00e1 E, Mar\u00edn F, Gonz\u00e1lez J et al (2008) Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications. J Card Fail 14:414\u2013419. https:\/\/doi.org\/10.1016\/j.cardfail.2008.02.006","journal-title":"J Card Fail"},{"key":"11961_CR32","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.jacc.2010.05.010","volume":"56","author":"R O\u2019Hanlon","year":"2010","unstructured":"O\u2019Hanlon R, Grasso A, Roughton M et al (2010) Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol 56:867\u2013874. https:\/\/doi.org\/10.1016\/j.jacc.2010.05.010","journal-title":"J Am Coll Cardiol"},{"key":"11961_CR33","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1161\/CIRCIMAGING.111.963819","volume":"5","author":"E Appelbaum","year":"2012","unstructured":"Appelbaum E, Maron BJ, Adabag S et al (2012) Intermediate-signal-intensity late gadolinium enhancement predicts ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy. Circ Cardiovasc Imaging 5:78\u201385. https:\/\/doi.org\/10.1161\/CIRCIMAGING.111.963819","journal-title":"Circ Cardiovasc Imaging"},{"key":"11961_CR34","doi-asserted-by":"publisher","first-page":"e000124","DOI":"10.1136\/openhrt-2014-000124","volume":"1","author":"K Suwa","year":"2014","unstructured":"Suwa K, Satoh H, Sano M et al (2014) Functional, morphological and electrocardiographical abnormalities in patients with apical hypertrophic cardiomyopathy and apical aneurysm: correlation with cardiac MR. Open Heart 1:e000124. https:\/\/doi.org\/10.1136\/openhrt-2014-000124","journal-title":"Open Heart"},{"key":"11961_CR35","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.113.007094","volume":"130","author":"RH Chan","year":"2014","unstructured":"Chan RH, Maron BJ, Olivotto I et al (2014) Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. Circulation 130:484\u2013495. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.007094","journal-title":"Circulation"},{"key":"11961_CR36","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1159\/000377622","volume":"131","author":"D Magr\u00ec","year":"2015","unstructured":"Magr\u00ec D, Piccirillo G, Ricotta A et al (2015) Spatial QT dispersion predicts nonsustained ventricular tachycardia and correlates with confined systodiastolic dysfunction in hypertrophic cardiomyopathy. Cardiology 131:122\u2013129. https:\/\/doi.org\/10.1159\/000377622","journal-title":"Cardiology"},{"key":"11961_CR37","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/jce.12948","volume":"27","author":"AJA McLELLAN","year":"2016","unstructured":"McLELLAN AJA, Ellims AH, Prabhu S et al (2016) Diffuse ventricular fibrosis on cardiac magnetic resonance imaging associates with ventricular tachycardia in patients with hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol 27:571\u2013580. https:\/\/doi.org\/10.1111\/jce.12948","journal-title":"J Cardiovasc Electrophysiol"},{"key":"11961_CR38","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/jce.13855","volume":"30","author":"A Weissler-Snir","year":"2019","unstructured":"Weissler-Snir A, Hindieh W, Spears DA et al (2019) The relationship between the quantitative extent of late gadolinium enhancement and burden of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy: a delayed contrast-enhanced magnetic resonance study. J Cardiovasc Electrophysiol 30:651\u2013657. https:\/\/doi.org\/10.1111\/jce.13855","journal-title":"J Cardiovasc Electrophysiol"},{"key":"11961_CR39","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.amjcard.2020.06.040","volume":"131","author":"J Levine","year":"2020","unstructured":"Levine J, Collins JD, Ogele E et al (2020) Relation of late gadolinium enhancement and extracellular volume fraction to ventricular arrhythmias in hypertrophic cardiomyopathy. Am J Cardiol 131:104\u2013108. https:\/\/doi.org\/10.1016\/j.amjcard.2020.06.040","journal-title":"Am J Cardiol"},{"key":"11961_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-59804-8","volume":"10","author":"YJ Park","year":"2020","unstructured":"Park YJ, Park S-J, Kim E-K et al (2020) Semi-quantitative versus quantitative assessments of late gadolinium enhancement extent for predicting spontaneous ventricular tachyarrhythmia events in patients with hypertrophic cardiomyopathy. Sci Rep 10:2920. https:\/\/doi.org\/10.1038\/s41598-020-59804-8","journal-title":"Sci Rep"},{"key":"11961_CR41","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3390\/jpm12020294","volume":"12","author":"A Karabinowska-Ma\u0142ocha","year":"2022","unstructured":"Karabinowska-Ma\u0142ocha A, Dziewi\u0119cka E, Bany\u015b P et al (2022) The relationship between cardiac magnetic resonance-assessed replacement and interstitial fibrosis and ventricular arrhythmias in hypertrophic cardiomyopathy. J Pers Med 12:294. https:\/\/doi.org\/10.3390\/jpm12020294","journal-title":"J Pers Med"},{"key":"11961_CR42","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1007\/s00380-012-0300-3","volume":"28","author":"Y Hen","year":"2013","unstructured":"Hen Y, Iguchi N, Machida H et al (2013) High signal intensity on T2-weighted cardiac magnetic resonance imaging correlates with the ventricular tachyarrhythmia in hypertrophic cardiomyopathy. Heart Vessels 28:742\u2013749. https:\/\/doi.org\/10.1007\/s00380-012-0300-3","journal-title":"Heart Vessels"},{"key":"11961_CR43","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.amjcard.2009.09.045","volume":"105","author":"GD Aquaro","year":"2010","unstructured":"Aquaro GD, Masci P, Formisano F et al (2010) Usefulness of delayed enhancement by magnetic resonance imaging in hypertrophic cardiomyopathy as a marker of disease and its severity. Am J Cardiol 105:392\u2013397. https:\/\/doi.org\/10.1016\/j.amjcard.2009.09.045","journal-title":"Am J Cardiol"},{"key":"11961_CR44","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1161\/CIRCHEARTFAILURE.108.768119","volume":"1","author":"MS Maron","year":"2008","unstructured":"Maron MS, Appelbaum E, Harrigan CJ et al (2008) Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy. Circ Heart Fail 1:184\u2013191. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.108.768119","journal-title":"Circ Heart Fail"},{"key":"11961_CR45","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11010-016-2849-0","volume":"424","author":"V Rai","year":"2017","unstructured":"Rai V, Sharma P, Agrawal S, Agrawal DK (2017) Relevance of mouse models of cardiac fibrosis and hypertrophy in cardiac research. Mol Cell Biochem 424:123\u2013145. https:\/\/doi.org\/10.1007\/s11010-016-2849-0","journal-title":"Mol Cell Biochem"},{"key":"11961_CR46","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1161\/CIRCULATIONAHA.107.186093","volume":"116","author":"LT Cooper","year":"2007","unstructured":"Cooper LT, Baughman KL, Feldman AM et al (2007) The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation 116:2216\u20132233. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.186093","journal-title":"Circulation"},{"key":"11961_CR47","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.jacc.2010.05.007","volume":"56","author":"O Bruder","year":"2010","unstructured":"Bruder O, Wagner A, Jensen CJ et al (2010) Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 56:875\u2013887. https:\/\/doi.org\/10.1016\/j.jacc.2010.05.007","journal-title":"J Am Coll Cardiol"},{"key":"11961_CR48","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s10554-008-9292-6","volume":"24","author":"DH Kwon","year":"2008","unstructured":"Kwon DH, Setser RM, Popovi\u0107 ZB et al (2008) Association of myocardial fibrosis, electrocardiography and ventricular tachyarrhythmia in hypertrophic cardiomyopathy: a delayed contrast enhanced MRI study. Int J Cardiovasc Imaging 24:617\u2013625. https:\/\/doi.org\/10.1007\/s10554-008-9292-6","journal-title":"Int J Cardiovasc Imaging"},{"key":"11961_CR49","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jacc.2008.08.064","volume":"53","author":"A Rudolph","year":"2009","unstructured":"Rudolph A, Abdel-Aty H, Bohl S et al (2009) Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy. J Am Coll Cardiol 53:284\u2013291. https:\/\/doi.org\/10.1016\/j.jacc.2008.08.064","journal-title":"J Am Coll Cardiol"},{"key":"11961_CR50","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1016\/j.jacc.2004.03.035","volume":"43","author":"JCC Moon","year":"2004","unstructured":"Moon JCC, Reed E, Sheppard MN et al (2004) The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 43:2260\u20132264. https:\/\/doi.org\/10.1016\/j.jacc.2004.03.035","journal-title":"J Am Coll Cardiol"},{"key":"11961_CR51","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.cjca.2012.05.004","volume":"29","author":"C Prinz","year":"2013","unstructured":"Prinz C, Schwarz M, Ilic I et al (2013) Myocardial fibrosis severity on cardiac magnetic resonance imaging predicts sustained arrhythmic events in hypertrophic cardiomyopathy. Can J Cardiol 29:358\u2013363. https:\/\/doi.org\/10.1016\/j.cjca.2012.05.004","journal-title":"Can J Cardiol"},{"key":"11961_CR52","doi-asserted-by":"publisher","first-page":"e533","DOI":"10.1161\/CIR.0000000000000938","volume":"142","author":"SR Ommen","year":"2020","unstructured":"Ommen SR, Mital S, Burke MA et al (2020) 2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 142:e533\u2013e557. https:\/\/doi.org\/10.1161\/CIR.0000000000000938","journal-title":"Circulation"},{"key":"11961_CR53","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/S0735-1097(03)00189-X","volume":"41","author":"JCC Moon","year":"2003","unstructured":"Moon JCC, McKenna WJ, McCrohon JA et al (2003) Toward clinical risk assessment inhypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 41:1561\u20131567. https:\/\/doi.org\/10.1016\/S0735-1097(03)00189-X","journal-title":"J Am Coll Cardiol"},{"key":"11961_CR54","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1056\/NEJM199703133361107","volume":"336","author":"P Spirito","year":"1997","unstructured":"Spirito P, Seidman CE, McKenna WJ, Maron BJ (1997) The management of hypertrophic cardiomyopathy. N Engl J Med 336:775\u2013785. https:\/\/doi.org\/10.1056\/NEJM199703133361107","journal-title":"N Engl J Med"},{"key":"11961_CR55","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1136\/heartjnl-2015-307682","volume":"101","author":"A Briasoulis","year":"2015","unstructured":"Briasoulis A, Mallikethi-Reddy S, Palla M et al (2015) Myocardial fibrosis on cardiac magnetic resonance and cardiac outcomes in hypertrophic cardiomyopathy: a meta-analysis. Heart 101:1406\u20131411. https:\/\/doi.org\/10.1136\/heartjnl-2015-307682","journal-title":"Heart"},{"key":"11961_CR56","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.amjcard.2023.10.056","volume":"210","author":"Y He","year":"2024","unstructured":"He Y, Zhou J (2024) Reversed septal curvature is associated with nonsustained ventricular tachycardia in hypertrophic cardiomyopathy. Am J Cardiol 210:195\u2013200. https:\/\/doi.org\/10.1016\/j.amjcard.2023.10.056","journal-title":"Am J Cardiol"},{"key":"11961_CR57","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1161\/CIRCULATIONAHA.109.878579","volume":"121","author":"BJ Maron","year":"2010","unstructured":"Maron BJ (2010) Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy. Circulation 121:445\u2013456. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.878579","journal-title":"Circulation"},{"key":"11961_CR58","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.jacc.2018.06.048","volume":"72","author":"D Kitkungvan","year":"2018","unstructured":"Kitkungvan D, Nabi F, Kim RJ et al (2018) Myocardial fibrosis in patients with primary mitral regurgitation with and without prolapse. J Am Coll Cardiol 72:823\u2013834. https:\/\/doi.org\/10.1016\/j.jacc.2018.06.048","journal-title":"J Am Coll Cardiol"},{"key":"11961_CR59","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.jcmg.2016.02.031","volume":"9","author":"Z Weng","year":"2016","unstructured":"Weng Z, Yao J, Chan RH et al (2016) Prognostic value of LGE-CMR in HCM: a meta-analysis. JACC Cardiovasc Imaging 9:1392\u20131402. https:\/\/doi.org\/10.1016\/j.jcmg.2016.02.031","journal-title":"JACC Cardiovasc Imaging"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11961-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-025-11961-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11961-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T09:26:00Z","timestamp":1772443560000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-025-11961-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":59,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["11961"],"URL":"https:\/\/doi.org\/10.1007\/s00330-025-11961-y","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Ahmed Kamal Siddiqi.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"Dr. De Cecco receives research support from\/is a consultant for: Siemens, Cleerly, Elucid, Xeos, Bayer. No other conflicts of interest to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"One of the authors has significant statistical expertise.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"This study is a systematic review and meta-analysis, so written informed consent was not required for this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This study was a systematic review and meta-analysis, so Institutional Review Board approval was not required because of the nature of the study.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}